Lenzilumab blocks GM-CSF, stopping creation of ne
Post# of 144904
Leronlimab blocks trafficking of inflammatory white blood cells to areas of inflammation, restores some of these same cells to a normal infection fighting, rather than inflammatory state, and restores ability of immune system to fight the virus.
Lenzilumab can mitigate the cytokine storm, but pales in comparison to leronlimab.
I implore you to read Dr. Patterson’s manuscript on RANTES, Covid and leronlimab and/or watch his TED talk.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)